Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences

@article{Aringhieri2018MolecularTO,
  title={Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences},
  author={Stefano Aringhieri and M. Carli and Shivakumar Kolachalam and Valeria Verdesca and E. Cini and M. Rossi and P. McCormick and G. Corsini and R. Maggio and M. Scarselli},
  journal={Pharmacology & Therapeutics},
  year={2018},
  volume={192},
  pages={20–41}
}
  • Stefano Aringhieri, M. Carli, +7 authors M. Scarselli
  • Published 2018
  • Medicine, Biology
  • Pharmacology & Therapeutics
  • ABSTRACT The introduction of atypical antipsychotics (AAPs) since the discovery of its prototypical drug clozapine has been a revolutionary pharmacological step for treating psychotic patients as these allow a significant recovery not only in terms of hospitalization and reduction in symptoms severity, but also in terms of safety, socialization and better rehabilitation in the society. Regarding the mechanism of action, AAPs are weak D2 receptor antagonists and they act beyond D2 antagonism… CONTINUE READING
    Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics
    Current Concepts and Treatments of Schizophrenia
    25
    Insulin Resistance in Schizophrenia.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 355 REFERENCES
    Update on typical and atypical antipsychotic drugs.
    242
    Antipsychotic drug actions on gene modulation and signaling mechanisms.
    65
    α-Adrenoceptor modulation hypothesis of antipsychotic atypicality
    108